Researchers discovered that embryos must clear maternal mRNAs to develop properly. When cleanup fails, it causes aberrant ...

In early November 2025, Akeso announced a series of major developments in its oncology portfolio, including statistically significant Phase III survival results for ivonescimab in EGFR-mutated lung ...

The 9 therapeutics stocks we track reported a mixed Q3. As a group, revenues beat analysts’ consensus estimates by 5.7%. In ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: A precisely timed mRNA shot could help many cancer patients live longer.

US mRNA-based therapeutics company Strand Therapeutics has announced the promotion of Prashant Nambiar to chief scientific ...

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is scheduled to meet on December 4 and 5, ...

PRNewswire/ -- iLeukon Therapeutics, Inc., a San Diego-based clinical-stage biotechnology company developing next-generation mRNA-based immunotherapies, announced new clinical results from the ongoing ...

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Generative AI is being used to design molecules and predict properties. In clinical trials, AI is helpful in selecting ...

Many climate scientists call our current epoch the “Anthropocene” — the first human-driven climate era. Many technologists ...